1:13 PM
 | 
Jan 05, 2018
 |  BC Week In Review  |  Financial News  |  Completed Offerings

NexImmune raises $23M series A

NexImmune Inc. (Gaithersburg, Md.) raised $23 million on Jan. 2 in a series A round co-led by new investor ArrowMark Partners and existing investor Barer & Son Capital. Existing investor Piedmont Capital also participated.

The immuno-oncology company expects the...

Read the full 180 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >